DENDRITIC cells comprise a system of highly efficient antigen-presenting cells which initiate immune responses such as the sensitization of T cells restricted by major histocompatibility complex molecules, the rejection of organ transplants and the formation of T-cell-dependent antibodies. Dendritic cells are found in many non-lymphoid tissues, such as skin (Langerhans cells) and mucosa, and they migrate after antigen capture through the afferent lymph or the bloodstream to lymphoid organs, where they efficiently present antigen to T cells1. Dendritic cells are difficult to isolate and, although they originate from bone marrow2,3 their site of maturation and the conditions that direct their growth and differentiation are still poorly characterized. Granulocyte macrophage-colony stimulating factor (GM-CSF) favours the outgrowth of dendritic cells from mouse peripheral blood4. Here we extend this finding to man and demonstrate that cooperation between GM-CSF and tumour necrosis factor-α (TNF-α) is crucial for the generation of human dendritic/Langerhans cells from CD34+ haematopoietic progenitors. The availability of large numbers of these cells should now facilitate the understanding of their role in immunological regulation and disorder.
This is a preview of subscription content, access via your institution
Open Access articles citing this article.
Cellular & Molecular Immunology Open Access 03 September 2021
Stem Cell Research & Therapy Open Access 29 June 2020
Nature Communications Open Access 28 April 2020
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Rent or buy this article
Prices vary by article type
Prices may be subject to local taxes which are calculated during checkout
Steinman, R. M. A. Rev. Immun. 9, 271–296 (1991).
Steinman, R. M., Lustig, D. S. & Cohn, Z. A. J. exp. Med. 139, 1431–1445 (1974).
Katz, S. I., Tamaki, K. & Sachs, D. H. Nature 282, 324–326 (1979).
Inaba, K. et al. J. exp. Med. 175, 1157–1167 (1992).
Caux, C. et al. Blood 75, 2292–2298 (1990).
Caux, C. et al. Blood 78, 635–644 (1991).
van de Rijn, M. et al. Hum. Immun. 9, 201–210 (1984).
Van Voorhis, W. C. et al. J. exp. Med. 158, 171–191 (1983).
Crow, M. K. & Kunkel, H. G. Clin. exp. Immun. 49, 338–346 (1982).
Witmer-Pack, M. D., Olivier, W., Valinsky, J., Schuler, G. & Steinman, R. M. J. exp. Med. 166, 1484–1498 (1987).
Heufler, C., Koch, F. & Schuler, G. J. exp. Med. 167, 700–705 (1987).
Koch, F. et al. J. exp. Med. 171, 159–172 (1990).
Gabbianelli, M. et al. Science 249, 1561–1564 (1990).
Djeu, J. Y. in Tumour Necrosis Factors: The Molecules and Their Emerging Role in Medicine (ed. Beutler, B.) 531–537 (Raven, New York, 1992).
Metcalf, D. Science 254, 529–533 (1991).
Luger, T. A. Acta derm. venereol. 69, 61–76 (1989).
Malik, S. T. A. in Tumor Necrosis Factors: The Molecules and Their Emerging Role in Medicine (ed. Beutler, B.) 407–423 (Raven, New York, 1992).
Ghiara, P., Borascki, D., Neucroni, L., Ghezzi, P. & Toglabue, A. J. Immun. 139, 1753–1758 (1987).
Van Voorhis, W. C., Hair, L. S., Steinman, R. M. & Kaplan, G. J. exp. Med. 155, 1172–1187 (1982).
Freudenthal, P. S. & Steinman, R. M. Proc. natn. Acad. Sci. U.S.A. 87, 7698–7702 (1990).
Romani, N. et al. J. invest. Dermatol. 93, 600–609 (1989).
Knight, S. C., Macatonia, S. E., Bedford, P. A. & Patterson, S. in Accessory Cells in HIV and Other Retroviral Infections (eds Racz, P., Dijkstra, C. D. & Gluckman, J. C.) 145–154 (Karger, Basel, 1991).
Langhoff, E. et al. Proc. natn. Acad. SCi. U.S.A. 88, 7998–8002 (1991).
Tschachler, E. et al. J. invest. Dermatol. 88, 233–237 (1987).
Cameron, P. U. et al. Science 257, 383–387 (1992).
Sornasse, T. et al. J. exp. Med. 175, 15–21 (1992).
Dezutter-Dambuyant, C. et al Hybridoma 8, 199–208 (1989).
Dezutter-Dambuyant, C., Schmiktt, D., Faure, M., Horisberger, M. & Thivolet, J. J. invest. Derm. 84, 465–468 (1985).
Hart, D. N. J. & McKenzie, J. L. J. exp. Med. 168, 157–160 (1988).
About this article
Cite this article
Caux, C., Dezutter-Dambuyant, C., Schmitt, D. et al. GM-CSF and TNF-α cooperate in the generation of dendritic Langerhans cells. Nature 360, 258–261 (1992). https://doi.org/10.1038/360258a0
This article is cited by
Cellular & Molecular Immunology (2022)
Nature Reviews Immunology (2021)
Stem Cell Research & Therapy (2020)
Nature Communications (2020)
Highly efficient CRISPR-targeting of the murine Hipp11 intergenic region supports inducible human transgene expression
Molecular Biology Reports (2020)